BioMedix Vascular Solutions, Inc. Invited to Participate in the California P.A.D. Task Force Committee

Friday, February 5, 2010 Press Release
Email Print This Page Comment
Font : A-A+

SACRAMENTO, Calif., Feb. 4 /PRNewswire/ -- BioMedix Vascular Solutions, Inc. announced today that John

Romans, CEO and Meg Heim, RN, Vice President of Marketing have been invited to participate as members of the P.A.D. Task Force Committee on behalf of the Governor of California,
Arnold Schwarzenegger
, The California Podiatric Medical Association and the California Department of Chronic Disease and Injury Prevention (CDPH).  The committee will meet today, February 4th, 2010 in the California State Capitol, Governors conference room.  

The meeting will be led by Dr. Michael R. Jaff, P.A.D. Task Force Chairman and Moderator, Associate Professor of Medicine, Harvard Medical School, Medical Director, Vascular Center, Massachusetts General Hospital, Boston, Massachusetts and comprised of 15 respected medical scholars. The goal of the Committee is to outline a path of preventative wellness including a collaborative care approach that will support the early identification and treatment of P.A.D., leading to decreased cost and better outcomes for the people of California. The Governor's office and the Committee are dedicated to understanding the impact of P.A.D. on the people within the state of California, build awareness of this highly under diagnosed disease through a collaborative care model supported by a dedicated team including Podiatric Physicians, Primary Care Physicians and Vascular Specialists.

Additionally, a Committee goal will be to generate a position paper centered on recommendation guidelines for statewide initiation of P.A.D. awareness and surveillance of at risk patients to be published in the next year.

About BioMedix

BioMedix Vascular Solutions, Inc. provides an integrated suite of hardware, software and online services designed to cost-effectively detect Peripheral Arterial Disease (P.A.D.) and Chronic Venous Insufficiency (CVI). Vascular specialists, primary care providers, hospitals and health systems use our products to identify these patients. Our devices and software reduce mistakes, provide data for sound analysis, build practice revenue and streamline reimbursement while providing a platform that supports the continuum of care and increased quality outcomes. For more information, call 877-854-0014 or log on to www.BioMedix.com.

Website: www.BioMedix.com

SOURCE BioMedix Vascular Solutions, Inc.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook